O'Quinn S - Search Results

1

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.

2

Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary.

O'Quinn S, Shih VH, Martin UJ, Meyers O, Crooks P, Bailey J, Slagle AF. O'Quinn S, et al. Int Forum Allergy Rhinol. 2022 Aug;12(8):996-1005. doi: 10.1002/alr.22952. Epub 2022 Jan 10. Int Forum Allergy Rhinol. 2022. PMID: 34921526 Free PMC article.

3

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma.

O'Quinn S, Xu X, Hirsch I. O'Quinn S, et al. J Asthma Allergy. 2019 Jan 23;12:21-33. doi: 10.2147/JAA.S190221. eCollection 2019. J Asthma Allergy. 2019. PMID: 30774388 Free PMC article.

4

Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY.

Corren J, Garcia Gil E, Griffiths JM, Parnes JR, van der Merwe R, Sałapa K, O'Quinn S. Corren J, et al. Ann Allergy Asthma Immunol. 2021 Feb;126(2):187-193. doi: 10.1016/j.anai.2020.10.008. Epub 2020 Oct 23. Ann Allergy Asthma Immunol. 2021. PMID: 33169672 Free article. Clinical Trial.

5

Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States.

Panettieri RA Jr, Chipps BE, Moore WC, Soong W, Carr WW, Kreindler JL, O'Quinn S, Trudo F, Ambrose CS. Panettieri RA Jr, et al. Among authors: o quinn s. J Asthma. 2022 Sep;59(9):1859-1868. doi: 10.1080/02770903.2021.1963766. Epub 2021 Nov 5. J Asthma. 2022. PMID: 34374622

6

Silverberg JI, Guttman-Yassky E, Gooderham M, Worm M, Rippon S, O'Quinn S, van der Merwe R, Kragh N, Kurbasic A, Wollenberg A. Silverberg JI, et al. Among authors: o quinn s. Ann Allergy Asthma Immunol. 2021 May;126(5):576-583.e4. doi: 10.1016/j.anai.2020.12.004. Epub 2020 Dec 15. Ann Allergy Asthma Immunol. 2021. PMID: 33333295 Free article. Clinical Trial.

7

Problems of disability and rehabilitation in patients with chronic skin diseases.

O'Quinn SE, Cole J, Many H. O'Quinn SE, et al. Arch Dermatol. 1972 Jan;105(1):35-41. Arch Dermatol. 1972. PMID: 5009621 No abstract available.

8

Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents.

Ho CN, O'Quinn S, Bailey J, Meyers O, Slagle AF, Dellon ES, Datto C. Ho CN, et al. Among authors: o quinn s. Orphanet J Rare Dis. 2021 Nov 24;16(1):495. doi: 10.1186/s13023-021-02107-6. Orphanet J Rare Dis. 2021. PMID: 34819137 Free PMC article.

9

Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).

Globe G, Currie B, Leidy NK, Jones P, Mannino D, Martinez F, Klekotka P, O'Quinn S, Karlsson N, Wiklund I. Globe G, et al. Health Qual Life Outcomes. 2016 Jul 16;14(1):104. doi: 10.1186/s12955-016-0506-7. Health Qual Life Outcomes. 2016. PMID: 27424173 Free PMC article.

10

Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.

Bacci ED, O'Quinn S, Leidy NK, Murray L, Vernon M. Bacci ED, et al. Respir Med. 2018 Jan;134:130-138. doi: 10.1016/j.rmed.2017.11.011. Epub 2017 Nov 26. Respir Med. 2018. PMID: 29413500 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page